HPV detection and typing in scrapes from HIV-infected patients;Detección y tipado de Papillomavirus humano en raspados de pacientes infectados por el virus de la inmunodeficiencia humana

Actas Dermo-Sifiliograficas

Volumn 94, Issue 1, 2003, Pages 17-23

  Zarco Olivo, Carlos ^a   Postigo Llorente, Concepción ^a   Llamas Martín, Rafael ^a   Suárez Moya, Avelina ^b   Picazo de la Garza, Juan J ^b   Castaño Suárez, Esther ^a   Guerra Tapia, Aurora ^a   Iglesias Díez, Luis ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Diagnosis; Human immunodeficiency virus; Human Papillomavirus; Polymerase chain reaction

Indexed keywords

CD4 ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CONDYLOMA; DNA HYBRIDIZATION; DNA ISOLATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS DETECTION; VIRUS ONCOGENE; VIRUS TYPING; WART VIRUS;

EID: 0038517912     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(03)79183-2     Document Type: Article

References (39)

1. Boyle J, Briggs JD, Mackie RM, Junor BJR, Aitchison TC. Cancer, warts and sunshine in renal transplant patients: a case control study. Lancet 1984;1:702-5.
2. Chopra KF, Tyring SK. The impact of the human immunodeficiency virus on the human papillomavirus epidemic. Arch Dermatol 1997;133:629-33.
3. Frisch M, Biggar RJ, Goedert JJ. HPV-associated cancers in patients with HIV infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;20:1500-10.
4. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993;27:133-45.
5. Arany I, Tyring SK. Status of local cellular immunity in interferon-responsive and non-responsive human papillomavirus-associated lesions. Sex Trans Dis 1996;23:475-80.
6. Vernon SD, Reeves WC, Clancy KA. A longitudinal study of HPV-DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1994;169:1108-12.
7. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC. HPV infection in women infected with the HIV. N Engl J Med 1997;337:1343-9.
8. Critchlow CW, Surawicz CM, Holmes KK, Kuipers J, Daling JR, Hawes SE, et al. Prospective study of high-grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995;9:1255-62.
9. Weedon D, Strutton G. Skin pathology. Edinburgh: Churchill Livingstone; 1997.
10. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001;15:2157-64.
11. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in HIV-positive and high-risk HIV-negative women. J Infect Dis 2001;183:383-91.
12. Coutlee F, Mayrand MH, Provencher D, Franco E. The future of HPV testing in clinical laboratories and applied virology research. Clin Diagn Virol 1997;8:123-41.
13. Velasco J, de Oña M. Diagnóstico de la infección por VPH. En: Palacio V, editor. Infección VPH en el área genital: clínica, diagnóstico y tratamiento. Madrid: 3M España, SA; 2000. p. 223-43.
14. Pérez MC. Detección y tipificación de papillomavirus humano genital por amplificación genómica. Tesis doctoral. Universidad Complutense, Madrid; 2001.
15. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of PCR amplification for the detection of genital HPV types. Cancer Cells 1989;7:209-14.
16. Aznar J. Patogenia y papel oncogénico de los papilomavirus humanos. En: Palacio V, editor. Infección VPH en el área genital: clínica, diagnóstico y tratamiento. Madrid: 3M España, SA; 2000. p. 49-57.
17. Strand A, Rylander E, Evandeer M, Wadell G. Genital HPV infection among patients attending an STD clinic. Genitourin Med 1993;69:446-9.
18. Sobhani I, Vuagnat A, Walker F, Vissuzaine C, Mirin B, Hervatin F. Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 2001;120:857-66.
19. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002;359:108-13.
20. Palefsky JM. Anal squamous intraepithelial lesions in HIV-positive men and women. Semin Oncol 2000;27:471-9.
21. Gomousa MM, Gialama E, Gomousas N, Gialama G. Genital HPV infection and associated penile intraepithelial neoplasia in males infected with the HIV. Acta Cytol 2000;44:305-9.
22. Mayrand MH, Coutlee F, Hanins C, Lapointe N, Forest P, De Ladurantaye M, et al. Detection of HPV type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 2000;38:3388-93.
23. Bollen LJ, Tjong a Hung SP, Van der Velden J, Mol BW, Boer K, Ten Kate FJ, et al. Clearence of cervical HPV infection by treatment for cervical dysplasia. Sex Trans Dis 1997;24:456-60.
24. Voltz JM, Drobacheff C, Derancourt C, Coumes-Marquet S, Mougin C, Laurent R. Lèsions anogénitales à papillomavirus chez 121 hommes séropositifs pour le VIH. Ann Dermatol Venereol 1999;126:424-9.
25. Breese PL, Judson FN, Penley KA, Douglas JM. Anal HPV infection among homosexual and bisexual men: prevalence of type-specific infection and association with HIV. Sex Trans Dis 1995;22:7-14.
26. De Roda AM, Walboomers JMM, Hopman E, Bleker OP, Helmerhorst TM, Rozendoal L, et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol 1995;46:97-102.
27. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997;36:659-85.
28. Mansat E, Dantal J, Hourmant M, Litoux P, Soulillou JP, Dreno B. Frequency of mucosal HPV DNA detection in skin lesions of renal transplant patients. Transpl Int 1997;10:137-40.
29. Palefsy JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for HPV infection of the anal canal in HIV-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-7.
30. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, et al. Prevalence, incidence, and type-specific persistence of HPV in HIV-positive and HIV-negative women. J Infect Dis 2001;184:682-90.
31. Unger ER, Vernon SD, Lee DR, Miller DL, Sharma S, Clancy KA et al. Human papillomavirus type in anal epithelial lesions is influenced by HIV. Arch Pathol Lab Med 1997;121:820-4.
32. Cuesta KH, Palazzo JP, Mittal KR. Detection of HPV in verrucous carcinoma from HIV-seropositive patients. J Cutan Pathol 1998;25:165-70.
33. Friedman HB, Saah AJ, Sherman ME, Busseniers AE, Blackwelder WC, Kaslow RA, et al. HPV, anal squamous intraepithelial lesions, and HIV in a cohort of gay men. J Infect Dis 1998;178:45-52.
34. Arany I, Tyring SK. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum. Int J STD AIDS 1998;9:268-71.
35. Palefsky JM. HPV infection and anogenital neoplasia in HIV-positive men and women. J Natl Cancer Inst Monogr 1998;23:15-20.
36. Surawicz CM, Critchlow C, Sayer J, Hurt C, Hawes S, Kirby P, et al. High grade anal dysplasia in visually normal mucosa in homosexual men: seven cases. Am J Gastroenterol 1995;90:1776-8.
37. Matczak E. Human papillomavirus infection: an emerging problem in anal and other squamous cell cancers. Gastroenterology 2001;120:1046-8.
38. De Sanjose S, Bosch XF, Muñoz N, Chichareon S, Ngelangel C, Balaguero L, et al. Screening for genital HPV: results from an international validation study on HPV sampling techniques. Diagn Mol Pathol 1999;8:26-31.
39. Kuhler C, Milde K, Helling G, Salfeler A, Peimann C, Loning T. PCR-associated papillomavirus detection in cervicovaginal smears: stratification by clinical risk and cytology reports. Virchows Arch 1994;425:157-63.